Quantification of Global Cerebral Atrophy in Multiple Sclerosis from 3T MRI Using SPM: The Role of Misclassification Errors

Journal of Neuroimaging

Volumn 25, Issue 2, 2015, Pages 191-199

  Dell'Oglio, Elisa ^a   Ceccarelli, Antonia ^a   Glanz, Bonnie I ^a   Healy, Brian C ^a   Tauhid, Shahamat ^a   Arora, Ashish ^a   Saravanan, Nikila ^a   Bruha, Matthew J ^a   Vartanian, Alexander V ^a   Dupuy, Sheena L ^a   Benedict, Ralph H B ^b   Bakshi, Rohit ^a   Neema, Mohit ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Brain atrophy; Gray matter; Lesions; MRI; Multiple sclerosis; Segmentation

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN MAPPING; BRAIN SIZE; COGNITION; CONTROLLED STUDY; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; STATISTICAL ANALYSIS; STATISTICAL PARAMETRIC MAPPING V 8; THREE DIMENSIONAL IMAGING; THREE DIMENSIONAL T1 WEIGHTED MAGNETIC RESONANCE IMAGING; WHITE MATTER; ALGORITHM; ARTIFACT; ATROPHY; AUTOMATED PATTERN RECOGNITION; BRAIN; COMPUTER ASSISTED DIAGNOSIS; IMAGE ENHANCEMENT; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; ALGORITHMS; ARTIFACTS; ATROPHY; BRAIN; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; PATTERN RECOGNITION, AUTOMATED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84924530012     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/jon.12194     Document Type: Article

References (47)

1. Bermel RA, Bakshi R. The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 2006;5:158-170.
2. Sanfilipo MP, Benedict RH, Sharma J, et al. The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction. NeuroImage 2005;26:1068-1077.
3. Dalton CM, Chard DT, Davies GR, et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004;127:1101-1107.
4. Pirko I, Lucchinetti CF, Sriram S, et al. Gray matter involvement in multiple sclerosis. Neurology 2007;68:634-642.
5. Bakshi R, Thompson AJ, Rocca MA, et al. MRI in multiple sclerosis: current status and future prospects. Lancet Neurol 2008;7:615-625.
6. Kangarlu A. High-field magnetic resonance imaging. Neuroimag Clin N Am 2009;19:113-128.
7. Tardif CL, Collins DL, Pike GB. Regional impact of field strength on voxel-based morphometry results. Hum Brain Mapp 2010;31:943-957.
8. Tardif CL, Collins DL, Pike GB. Sensitivity of voxel-based morphometry analysis to choice of imaging protocol at 3T. NeuroImage 2009;44:827-838.
9. Wonderlick JS, Ziegler DA, Hosseini-Varnamkhasti P, et al. Reliability of MRI-derived cortical and subcortical morphometric measures: effects of pulse sequence, voxel geometry, and parallel imaging. NeuroImage 2009;44:1324-1333.
10. Ceccarelli A, Jackson JS, Tauhid S, et al. The impact of lesion in-painting and registration methods on voxel-based morphometry in detecting regional cerebral gray matter atrophy in multiple sclerosis. AJNR Am J Neuroradiol 2012;33:1579-1585.
11. Nakamura K, Fisher E. Segmentation of brain magnetic resonance images for measurement of gray matter atrophy in multiple sclerosis patients. NeuroImage 2009;44:769-776.
12. Neema M, Goldberg-Zimring D, Guss ZD, et al. 3T MRI relaxometry detects T2 prolongation in the cerebral normal-appearing white matter in multiple sclerosis. Neuroimage 2009;46:633-641.
13. Hasan KM, Walimuni IS, Abid H, et al. Multi-modal quantitative MRI investigation of brain tissue neurodegeneration in multiple sclerosis. J Magn Reson Imaging 2012;35:1300-1311.
14. Jones BC, Nair G, Shea CD, et al. Quantification of multiple-sclerosis-related brain atrophy in two heterogeneous MRI datasets using mixed-effects modeling. NeuroImage Clin 2013;13:171-179.
15. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann Neurol 2005;58:840-846.
16. Khoury S, Bakshi R. Cerebral pseudoatrophy or real atrophy after therapy in multiple sclerosis. Ann Neurol 2010;68:778-779.
17. Neema M, Guss ZD, Stankiewicz JM, et al. Normal findings on brain fluid-attenuated inversion recovery MR images at 3T. AJNR Am J Neuroradiol 2009;30:911-916.
18. Benedict RH, Cookfair D, Gavett R, et al. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc 2006;12:549-558.
19. Parmenter BA, Testa SM, Schretlen DJ, et al. The utility of regression-based norms in interpreting the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc 2010;16:6-16.
20. Deichmann R, Schwarzbauer C, Turner R. Optimisation of the 3D MDEFT sequence for anatomical brain imaging: technical implications at 1.5 and 3 T. NeuroImage 2004;21:757-767.
21. Ashburner J, Friston KJ. Unified segmentation. NeuroImage 2005;26:839-851.
22. Stankiewicz JM, Glanz BI, Healy BC, et al. Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis. J Neuroimaging 2011;21:e50-e56.
23. Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE T Med Imaging 1998;17:87-97.
24. Chard DT, Griffin CM, Parker GJ, et al. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 2002;125:327-337.
25. Cohen J. Statistical Power Analysis for the Behavioral Sciences, 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
26. Galdames FJ, Jaillet F, Perez CA. An accurate skull stripping method based on simplex meshes and histogram analysis for magnetic resonance images. J Neurosci Methods 2012;206:103-119.
27. Arora A, Moscufo N, Neema M, et al. Increasing efficiency of intracranial cavity determination from high-resolution 3 tesla(T) MRI scans of the brain. Neurology 2013;79:106-121.
28. Fisher E, Lee JC, Nakamura K, et al. Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 2008;64:255-265.
29. Ceccarelli A, Rocca MA, Pagani E, et al. A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes. NeuroImage 2008;42:315-322.
30. Helms G, Draganski B, Frackowiak R, et al. Improved segmentation of deep brain grey matter structures using magnetization transfer (MT) parameter maps. NeuroImage 2009;47:194-198.
31. Derakhshan M, Caramanos Z, Giacomini PS, et al. Evaluation of automated techniques for the quantification of grey matter atrophy in patients with multiple sclerosis. NeuroImage 2010;52:1261-1267.
32. Bermel RA, Innus MD, Tjoa CW, et al. Selective caudate atrophy in multiple sclerosis: a 3D MRI parcellation study. NeuroReport 2003;14:335-339.
33. Houtchens MK, Benedict RHB, Killiany R, et al. Thalamic atrophy and cognition in multiple sclerosis. Neurology 2007;69:1213-1223.
34. Bergsland N, Horakova D, Dwyer MG, et al. Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 2012;33:1573-1578.
35. Chard DT, Jackson JS, Miller DH, et al. Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes. J Magn Reson Imaging 2010;32:223-228.
36. Gelineau-Morel R, Tomassini V, Jenkinson M, et al. The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis. Hum Brain Mapp 2012;33:2802-2814.
37. Klawiter EC, Ceccarelli A, Arora A, et al. Corpus callosum atrophy correlates with gray matter atrophy in patients with multiple sclerosis. J Neuroimaging [Epub ahead of print May 9, 2014; DOI: 10.1111/jon.12124].
38. Benedict RH, Carone DA, Bakshi R. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis. J Neuroimaging 2004;14:36S-45S.
39. Amato MP, Zipoli V, Portaccio E. Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J Neurol Sci 2006;245:41-46.
40. Sanfilipo MP, Benedict RH, Weinstock-Guttman B, et al. Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis. Neurology 2006;66:685-692.
41. Benedict RH, Bruce JM, Dwyer MG, et al. Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. Arch Neurol 2006;63:1301-1306.
42. Calabrese M, Agosta F, Rinaldi F, et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 2009;66:1144-1150.
43. Morgen K, Sammer G, Courtney SM, et al. Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS. NeuroImage 2006;30:891-898.
44. Sicotte NL, Kern KC, Giesser BS, et al. Regional hippocampal atrophy in multiple sclerosis. Brain 2008;131:1134-1141.
45. Tjoa CW, Benedict RHB, Weinstock-Guttman B, et al. MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis. J Neurol Sci 2005;234:17-24.
46. Shiee N, Bazin PL, Zackowski KM, et al. Revisiting brain atrophy and its relationship to disability in multiple sclerosis. PLoS One 2012;7:e37049.
47. Cohen AB, Neema M, Arora A, et al. The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis. J Neuroimaging 2012;22:122-128.